Saluda Medical Pty Ltd.

Saluda is preparing to market the Evoke SCS system in the US as the only available SCS system that treats chronic pain by instantaneously reading and reacting to the nerves’ response to stimulation.

Medtronic PLC and Boston Scientific Corp. are backing Saluda Medical 's spinal cord technology with a fresh round of financing. The Australian company has secured a four-year term loan agreement w

January and February saw a few crossover partnerships, where the line between drugs and devices become blurry and innovative therapies emerge from increasingly multidisciplinary alliances. Neuromodula

When it comes to the spinal cord stimulation market, Abbott Laboratories Inc. , Medtronic PLC and Boston Scientific Corp. are on top of the world, but one start-up from Down Under hopes to